NPI: 1992744114 · ANCHORAGE, AK 99508 · 207RC0000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,818 | $393K |
| 2019 | 6,707 | $454K |
| 2020 | 6,793 | $379K |
| 2021 | 9,135 | $605K |
| 2022 | 9,863 | $605K |
| 2023 | 11,689 | $590K |
| 2024 | 8,617 | $447K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | 16,717 | 15,429 | $1.57M | |
| 93306 | 7,303 | 7,041 | $964K | |
| 99204 | 801 | 758 | $140K | |
| 93296 | 9,061 | 8,774 | $117K | |
| 99213 | 1,566 | 1,476 | $95K | |
| 93294 | 5,034 | 4,873 | $82K | |
| 93295 | 2,884 | 2,800 | $82K | |
| 99233 | Prolong inpt eval add15 m | 635 | 292 | $68K |
| 93000 | 3,875 | 3,669 | $52K | |
| 93298 | 2,235 | 2,138 | $52K | |
| 93297 | 1,967 | 1,906 | $45K | |
| 99232 | 638 | 313 | $43K | |
| 99215 | Prolong outpt/office vis | 357 | 330 | $39K |
| 93280 | 909 | 877 | $32K | |
| G2066 | Inter devc remote 30d | 3,079 | 2,949 | $19K |
| 93299 | 218 | 210 | $14K | |
| 93015 | 275 | 254 | $14K | |
| 99203 | 114 | 94 | $11K | |
| 99152 | 240 | 228 | $9K | |
| 99223 | Prolong inpt eval add15 m | 30 | 27 | $4K |
| 75561 | 18 | 12 | $4K | |
| 78452 | 15 | 14 | $4K | |
| 93458 | 12 | 12 | $3K | |
| J2785 | Regadenoson injection | 37 | 30 | $2K |
| 93312 | 15 | 13 | $2K | |
| 93272 | 44 | 42 | $1K | |
| 99443 | 12 | 12 | $1K | |
| 93224 | 12 | 12 | $949.42 | |
| G2211 | Complex e/m visit add on | 388 | 369 | $817.88 |
| A9500 | Tc99m sestamibi | 13 | 13 | $780.00 |
| 93281 | 12 | 12 | $652.16 | |
| J0153 | Adenosine inj 1mg | 18 | 12 | $571.69 |
| 93284 | 13 | 12 | $552.89 | |
| 93320 | 14 | 13 | $269.51 | |
| 99211 | 17 | 14 | $245.50 | |
| 93270 | 17 | 17 | $139.68 | |
| 93325 | 14 | 13 | $47.57 | |
| 82565 | 13 | 12 | $17.48 |